인쇄하기
취소

Simvastatin generic drugs expanding their presence in domestic anti-hyperlipemia drug market

Published: 2003-12-17 07:00:00
Updated: 2003-12-17 07:00:00
Following the patent expiration of MSD Korea's Zocor, a number of domestic pharmaceutical firms have been rushing to release simvastatin generic versions this year and as a result, their market share is rapidly increasing by more than 70 percent with the combined sales of 16.0 billion won.

The Korea Food and Administration approved a total of 78 simvastatin generic drugs (including raw mater...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.